COGNITION THERAPEUTICS INC
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$47.8M | -$54.0M | -$50.7M | -$43.6M | -$28.6M |
| Operating expenses | $47.8M | $54.0M | $50.7M | $43.6M | $28.6M |
| Cash from operations | -$24.6M | -$28.5M | -$16.0M | -$18.5M | -$3.6M |
| Capital expenditure | — | $4,000 | $147,000 | $171,000 | $27,000 |
| Free cash flow | — | -$28.5M | -$16.2M | -$18.7M | -$3.7M |
| Total assets | $48.4M | $30.2M | $35.2M | $50.4M | $59.1M |
| Total liabilities | $14.1M | $11.5M | $10.7M | $10.2M | $7.9M |
Shares outstanding 89.5M · Free float 80.3%
Annual filing data through FY ended December 31, 2025; float as of July 13, 2026.